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Abstract
In multicellular organisms, morphogenesis is a highly coordinated process that requires dynamically regulated adhesion
between cells. An excellent example of cellular morphogenesis is the formation of the neural tube from the flattened
epithelium of the neural plate. Cysteine-rich motor neuron protein 1 (CRIM1) is a single-pass (type 1) transmembrane
protein that is expressed in neural structures beginning at the neural plate stage. In the frog Xenopus laevis, loss of function
studies using CRIM1 antisense morpholino oligonucleotides resulted in a failure of neural development. The CRIM1
knockdown phenotype was, in some cases, mild and resulted in perturbed neural fold morphogenesis. In severely affected
embryos there was a dramatic failure of cell adhesion in the neural plate and complete absence of neural structures
subsequently. Investigation of the mechanism of CRIM1 function revealed that it can form complexes with ß-catenin and
cadherins, albeit indirectly, via the cytosolic domain. Consistent with this, CRIM1 knockdown resulted in diminished levels of
cadherins and ß-catenin in junctional complexes in the neural plate. We conclude that CRIM1 is critical for cell-cell adhesion
during neural development because it is required for the function of cadherin-dependent junctions.
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Introduction
Development of multicellular organisms requires the coordinat-
ed movement of cells in a process generally referred to as
morphogenesis. Morphogenesis at the organismal scale can be
dramatic – for example, the closure of the neural tube – and
complex because it requires synchronizing distinct activities in
multiple tissue layers. Component activities of morphogenesis
include cell migration, cell elongation, process formation,
coordinated shape change during epithelial bending as well as
regionally increasing and decreasing tissue volumes driven by cell
proliferation and cell death.
The regulation of adhesive interactions is a key factor in control
of morphogenesis. Among adhesion molecules, cadherins have a
critical role [1,2,3]. The classical cadherins exist in a complex with
catenins. The catenins regulate association of cadherins with the
actin cytoskeleton, though binding may not be direct [3,4].
Association of cadherins with actin is likely mediated by the
bridging molecule eplin [5]. Adhesive activity of cadherins can be
regulated in a variety of ways [3] and this is clearly important in
permitting and mediating the cellular movements of morphogen-
esis. In some settings, catenins are essential for cell-cell adhesion.
For example, p120 catenin loss-of-function in the salivary gland
results in severe defects in adhesion accompanied by the down-
regulation of E-cadherin [6]. ß-catenin loss-of-function in the
presumptive lens results in a reduction of the F-actin cytoskeleton
and loss of cell adhesion [7]. Antisense oligonucleotide depletion of
both a-catenin and EP-cadherin in Xenopus embryos causes a
failure of cellular adhesion at blastula stages [8,9]. A two-tiered
regulation of E-cadherin has recently been reported in embryonic
epithelia of Drosophila whereby a stable cell-cell homophillic E-
cadherin complex pool and a more diffusible monomeric E-
cadherin pool co-exist at cell junctions [10]. These pools of E-
cadherin have different connections to the intracellular actin
network and must require different mechanisms for turnover and
regulation during embryonic morphogenesis.
Cysteine-rich motor neuron 1 (CRIM1) was originally identified
as a partial cDNA in an interaction screen [11] and in a screen for
secreted proteins (C. Tabin, personal communication). Assembly
of the full sequence representing the CRIM1 cDNA [11] revealed
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homology to insulin-like growth factor binding domains (IGFBP;
[11,12]) and a set of six cysteine-rich von Willebrand factor C
(vWC) repeats occupying the remaining extracellular domain. The
cysteine-rich repeats of CRIM1 are similar to those of chordin
[13] and its Drosophila homolog, short gastrulation [14] that can
bind bone morphogenetic proteins (BMPs) [15,16]. Another
protein that contains an IGFBP and single cysteine-rich domain
is Cyr61, a secreted heparin binding, extracellular matrix
associated protein that is required for normal gastrulation
movements [17]. CRIM1 is expressed in a variety of tissues and
cell types that include the vertebrate CNS [11] urogenital tract
[18] eye [19,20] and vascular system [21]. CRIM1 protein has
been localized to the endoplasmic reticulum [21,22] or to
junctional complexes upon stimulation of vascular endothelial
cells [21].
Analysis of CRIM1 function suggested it has a role in
vascular tube formation both in culture [21] and in vivo in the
fish [23]. Consistent with expression of CRIM1 in the neural
tube [11], over-expression of the CRIM1 ectodomain in the
chick neural tube reduces the numbers of certain spinal cord
neurons [20]. CRIM1 was also been proposed to be an
antagonist for bone morphogenetic proteins (BMPs) through
suppression of BMP maturation and sequestration in the Golgi
or at the cell surface [22]. This activity is dependent upon the
extracellular vWC repeats [22]. Expression of CRIM1 in the
chick neural tube was, however, insufficient to modulate ventral
patterning [20] where BMP activity is critical [24]. An
assessment of the function of crm-1,aC. elegans homologue of
CRIM1, has suggested a role in enhancing BMP signaling [25].
Identification of a CRIM1 hypomorphic mutant in the mouse
(CRIM1
KST264, [26]) that was generated by lacz insertional
mutagenesis has revealed that CRIM1 is involved in the
development of multiple organ systems including the limbs, eye
and kidney vascular system [26,27].
In the current study we have focused on understanding the
activity of the CRIM1 cytoplasmic domain, a region of 82 amino
acids that is highly conserved. Antisense oligonucleotide mediated
loss of function studies in Xenopus laevis revealed an essential role for
CRIM1 in neural plate cell adhesion. In these experiments there
was a loss of junctional cadherin labeling intensity, reduced
epithelial polarity and organization and ultimately, the sloughing
of neural plate cells. Based on this result we screened CRIM1
containing complexes for the presence of known adhesion
mediators. We found that the cytoplasmic domain of CRIM1
can form complexes with ß-catenin and cadherins, though this
interaction is probably indirect. Combined, these data suggest that
CRIM1 is essential for cadherin mediated cell-cell adhesion in the
developing nervous system.
Materials and Methods
Ethics Statements
All experiments were performed in accordance with institutional
guidelines under Institutional Animal Care and Use Committee
(IACUC) approval at Cincinnati Children’s Hospital Research
Foundation (CCHRF). IACUC at CCHRF approved the study
described in this manuscript with Animal Use Protocol number
0B12097.
Plasmid constructs
Plasmid constructs were generated using conventional methods
using full-length CRIM1 cDNA Xenopus laevis EST 5537401
(Invitrogen).
Cell lines and transfection
HEK 293T cells (ATCC, CRL-11268) were cultured in a
conventional manner. Cell lines were transfected with DNA
constructs using Fu-Gene (Roche) or Trans-IT (Mirus) reagents.
Morpholino experiments and in situ hybridization
Translation-blocking morpholino oligonucleotides (MOs) were
designed against xCRIM1a (XLCA) and xCRIM1b (XLCB)
(Gene Tools, LLC). The MOs were prepared at a concentration of
30 mg/mL in sterile water. We used a 10,000 MW fluorescent
dextran (Molecular Probes) or a GFP-encoding mRNA as lineage
tracers.
X. laevis eggs were fertilized in vitro and grown in 0.1X modified
Barth saline (MBS) [28], staged according to [29] and transferred
to 1X MBS, 4% Ficoll for microinjection. Embryos were injected
at the 4 to 16-cell stage in individual blastomeres and cultured in
0.1X MBS, 2% Ficoll at 18uC or in 0.1X MBS for longer
incubations. Embryos were fixed in 1X MEMFA at various stages
for analysis.
Antisense RNA probe synthesis and in situ hybridization on
whole embryos were performed as previously described [30].
cDNA from staged X. laevis embryos (stages 8 to 32) were a
generous gift from C. Wylie. We used PCR primers specific to the
59-UTR of xCRIM to amplify sequences from isolated cDNAs.
Protein analysis
Immunoblotting was performed using conventional chemilumi-
nescence methods. For immunoprecipitation, we lysed the cells in
a modifed IP buffer (50 mM Tris-Hcl, pH 7.4, 150 mM NaCl,
1 mM CaCl2, 1 mM MgCl2, 2% glycerol, 0.1% BSA, 0.5% NP-
40, and 0.5% Triton X-100). Cell lysates were incubated with the
antibodies and proteins precipitated with protein A agarose beads
(Invitrogen). Antibodies used for immunoprecipitation and/or
western analysis are as follows: mouse anti-V5 mAb (Invitrogen),
mouse anti-FLAG mAb (Sigma), rabbit anti-ß-catenin (H-102,
Santa Cruz), and mouse anti-N-cadherin (Zymed and H-63, Santa
Cruz).
Immunofluorescence labeling
Cryosection labeling was carried out as described [7] with rabbit
anti-ß-catenin (1:2500, Santa Cruz, SC-7199) and goat anti-rabbit
Alexa568 secondary (1:1000, Molecular Probes #A-11011)
antibodies. Whole mount staining was carried out as previously
described [31]. Antibodies were anti-C-cadherin or anti-E-
cadherin (6B6 or 5D3, respectively; Developmental Study
Hybridoma Bank, Iowa, 1:250), anti-activated caspase-3 (1:250,
BD Pharmingen 559565) and rabbit-anti-GFP Alexa488 (1:300,
Molecular Probes). Secondary antibodies were Cy5 goat anti-
mouse or Cy3 goat anti-rabbit IgG (1:300, Jackson Laboratory).
TUNEL labeling (Roche) was performed with manufacturer
protocols. One-way ANOVA statistical analysis was performed
using SPSS software.
Results
Knockdown of CRIM1 in Xenopus embryos causes defects
in neuronal structures development
Using available chick CRIM1 sequence (accession
#NM_204425) to design primer sets, we PCR amplified cDNA
products from a stage 28 Xenopus laevis cDNA library and identified
two distinct sequences that had extensive homology to chick
CRIM1. Based on the high degree of homology, these clone
families represented the Xenopus laevis A and B genes. We used this
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design PCR primers, antisense Morpholino oligonucleotides (MO,
Fig. 1A, Table 1) and in situ hybridization probes for Xenopus laevis
CRIM1.
RT-PCR analysis for CRIM1 on a staged series of embryos
(Fig. 1B) showed that CRIM1 mRNA is detected in the early
neurula at stage 12. For comparison, n-tubulin mRNA was detected
in the late neurula at stage 22. By in situ hybridization, CRIM1 was
detected in the neural plate of stage 12.5 embryos (Fig. 1C).
Expression of CRIM1 in neural structures continued and at stage
18, albeit faintly detected, in posterior neural tube (Fig. 1D) as well
as anterior neural structures including optic vesicles (Fig. 1E).
CRIM1 expression at stage 22 was detected in the early somites
and weakly in neural structures (Fig. 1F). The hindbrain, cement
gland and somites were all locations of CRIM1 expression at stage
35 (Fig. 1G).
CRIM1 loss-of-function experiments in Xenopus laevis were
performed using antisense MO-mediated translation and splicing
blocking [32,33]. Sequence differences in the 59 untranslated
region of the CRIM1 A and B genes (Fig. 1A) required that we use
a mixture of MOs (XLCAB, Table 1) for translation blocking. To
design splicing-blocking MOs, we first identified Xenopus tropicalis
Figure 1. CRIM1 is expressed in the neural plate and is required
for development of neural structures. (A) Antisense morpholino
oligo (MO) sequences and their complimentary targets on the Xenopus
laevis messenger sequences are indicated for both the translation
blocking MOs (upper) and the splice-donor blocking MOs (lower). (B)
RT-PCR assessment of CRIM1A transcript expression in developmentally
staged Xenopus laevis embryos. n-tubulin is a neuronal differentiation
marker and ornithine decarboxylase (ODC) a ubiquitously expressed
control. (C–G) In situ hybridizations for CRIM1A in Xenopus laevis
embryos. The dashed bracket in (C) indicates the neural plate region,
the arrowheads in (D) the neural tube and in (E) the optic vesicles. cg:
cement gland; hb: hindbrain. (H) Detection of unspliced or spliced
CRIM1A and B mRNA in uninjected embryos (UI) or those injected with
the 5-missense control (5mis) or splice blocking (XLCSD) MOs. The PCR
primer pair XCPF and XCPR1 detects unspliced mRNA while XCPF and
XCPR2 detect the spliced product. (I–L) CRIM1 loss-of-function
experiments where (I) is an uninjected control and (J–L) were injected
with XLCA and B MOs at 15 ng each. Small (J, arrowhead) or missing
eyes (K, arrowhead) often result. The embryo in (L) was coinjected with
10 kDa Alexa-fluor 488 dextran (green). l: lens; r: retina; nt: neural tube.
(M) Comparison of control embryo (upper) and embryo injected at the
2-cell stage bi-laterally with XLCAB at 30 ng each (lower). Develop-
mental stages as indicated.
doi:10.1371/journal.pone.0032635.g001
Table 1. Morpholino oligonucleotides used in this study.
X. laevis CRIM1 Morpholino Oligonucleotide Sequences:
XLCA 59-TCCCCGGCAGGTACATCCTTCCTCC-39
XLCB 59-CGGCAGGTACATCCTTCCTCCCCCG-39
5MXLCA 59-TCgCCcGCAGcTACATCgTTCgTCC-39
5MXLCB 59-CGcCAcGTACATTgTTCCTgCCgCG-39
SCMO 59-CCTCTTACCTCAGTTACAATTTATA -39
XLCSDA 59-ATGGCTGCTTACCTTCAATCCGTCT-39
XLCSDB 59-CTGCTTACCTTCAATCCGCCTCAGC-39
5MXLCSDA 59-ATcGCTcCTTAgCTTgAATCCcTCT-39
Nucleotides complementary to the start codon of CRIM1 are indicated in bold.
Control Morpholinos have either a 5 nucleotide mismatch (5 M) or are the
standard control Morpholino (SCMO) from GeneTools. Mismatched nucleotides
are indicated in lower case.
doi:10.1371/journal.pone.0032635.t001
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Browser) and used that sequence to PCR amplify and sequence
Xenopus laevis genomic clones. The CRIM1 A and B genes also had
sequence changes in the exon 2 splice donor region (Fig. 1A) that
necessitated a mix of MOs (XLCSDAB, Table 1) to target both
mRNAs. Using two sets of PCR primers that detected either
unspliced or spliced mRNA (Fig. 1H) we confirmed that the MOs
targeted to the splice donor of CRIM1 exon 2 suppressed splicing.
Translation and splicing blocking CRIM1 MOs injected into a
dorsal blastomere at the 4-cell stage produced dramatic effects on
the development of neural structures. In a typical experiment
where 15 ng each of XLCA and B were injected, more than 70%
of embryos had major defects including a small or missing eye on
the injected side (Table 2 and Fig. 1I, J, K, L). Tracing of MO
distribution with coinjected Dextran Alexa488 confirmed that the
affected region of the embryo received MO but that any
remaining neural tube was tracer negative (Fig. 1L). Histological
assessment of affected Xenopus embryos at stage 42 confirmed the
neural tube and eye were both missing on the injected side (data
not shown). In embryos injected bi-laterally at the 2-cell stage with
30 ng each XLCA and B MOs, a loss of anterior neural and head
structures resulted but ventral and posterior structures were
retained (Fig. 1M). This phenotype induced by loss of CRIM1 in
the whole embryo by administering the MOs at this stage
correlates well given the expression pattern of CRIM1 in the
developing neural plate.
Since the absence of an eye served as a simple read-out for
phenotype severity, we assessed changes from MOs injection in
different amounts. There was a dose response for both translation
and splicing blocking MOs and that each produced the same
phenotype (Table 2). Injection of ventral blastomeres with the
translation blocking XLCAB combination had a minimal effect
(Table 2, vent). MOs (Table 1) in which 5 of the nucleotides were
mismatched had a greatly reduced effect though this was not zero
(Table 2). Since 5 nucleotide mismatch MOs are known to retain
some activity at the concentrations used here [33] we also used the
standard control MO (GeneTools) that has no measurable activity
as a control and observed no obvious phenotype (Table 2).
We also determined whether co-injection of a MO-resistant
CRIM1 mRNA with the XLCAB MOs resulted in phenotypic
rescue. Though we did not observe a complete reversal of the
effects of the XLCAB MOs, the MO-resistant xCRIM1 mRNA
reduced the percentage of embryos showing small or missing eyes
(Table 2). Together, the activity of both MO types in producing
the same phenotype, the correlation of that phenotype with the
expression domain of CRIM1, suppression of CRIM1 mRNA
splicing with XLCSDAB MOs and a degree of phenotype rescue
with xCRIM1 expression suggest the antisense oligonucleotides
are specific.
The absence of neural structures in tailbud stage embryos was
consistent with the loss of neural plate integrity at earlier stages.
Examination of XLCAB MOs injected pigmented embryos at
Table 2. Phenotype summary for CRIM1 Morpholino injections.
Morpholino Oligos Injected Eye (Injected Side) Total Embryos
Normal Small Absent
Translation Blocking
Uninjected 100% 0% 0% 67
Standard Control 100% 0% 0% 22
5MXLCAB (15 ng ea) 89.8% 10.2% 0% 49
XLCA (10 ng) 64.3% 37.7% 0% 45
XLCA (20 ng) 18.2% 77.3% 4.5% 44
XLCB (10 ng) 54.8% 38.1% 7.1% 42
XLCB (20 ng) 7.3% 82.9% 9.8% 41
XLCAB (15 ng ea), vent
a 86.7% 13.3% 0% 15
XLCAB (5 ng ea) 40% 60% 0% 20
XLCAB (10 ng ea) 44.4% 50% 5.6% 18
XLCAB (15 ng ea) 22.8% 48.6% 28.6% 70
Splicing Blocking
Uninjected 100% 0% 0% 55
5MXLCSDA (15 ng) 68.9% 31.1% 0% 29
XLCSDA (15 ng) 0% 44.4% 55.6% 36
XLCSDB (15 ng) 33.3% 66.7% 0% 45
XLCSDAB (7.5 ng ea) 35.1% 64.9% 0% 37
XLCSDAB (15 ng ea) 13% 74% 13% 23
Rescue Experiment
Uninjected 100% 0% 0% 32
XLCAB (15 ng ea) 25% 66.7% 8.3% 36
XLCAB (15 ng ea) + MR
b CRIM1-FL (200 pg) 71.4% 28.6% 0% 70
a: ventral blastmeres instead of dorsal blastmeres were injected with morpholino oligos.
b: MR means morpholino oligonucleotide resistant.
doi:10.1371/journal.pone.0032635.t002
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that the injected side had defects in neural plate formation.
Specifically, failure of the neural plate boundary (the neural folds)
to move toward the midline produced embryos with a pronounced
asymmetry (Fig. 2). In many XLCAB MOs injected embryos, cells
were seen sloughing from the surface of the injected side (Fig. 2,
red arrowheads). In a typical experiment using 15 ng each XLCA
and XLCB (Table 2), 20/70 embryos (28.6%) show severe cell
sloughing. Time-lapse video microscopy of embryos bi-laterally
injected with MOs (dorsal blastomeres, XLCAB at the 4-cell stage)
in some cases showed a mild phenotype of delayed neural fold
morphogenesis with a failure of anterior neural tube closure
(Video S1) and in others a severe failure of cell adhesion across the
entire neural plate (Video S2). This suggested that CRIM1 might
have an essential role in promoting cell adhesion or suppressing
cell death within the neural plate.
Reduced cadherin junctional complexes is a primary
consequence of CRIM1 loss-of-function
To distinguish between these two possibilities, we first
determined whether the level or localization of cadherins that
are critical adhesion molecules in Xenopus neural plate [34] might
be affected in CRIM1 knockdown embryos. We coinjected
XLCAB MOs with a tracer mRNA encoding GFP at the 4-cell
stage and then performed whole-mount immunolabeling for
cadherins at stage 13 (early neurula stage). In these preparations,
an apical cadherin junctional complex is identified revealing
patterns of cell packing and cell size at the surface (Fig. 3). In this
case we controlled the experiment by injecting the GFP tracer
mRNA alone. In other experiments co-injecting control MOs with
dextran tracer gave identical results (Figs. 4, 5, 6). In control
embryos we see slight junction-to-junction variation in labeling
intensity for both E-cadherin (Fig. 3A) and C-cadherin (Fig. 3B),
but this did not correlate with GFP expression.
By contrast, when the GFP mRNA and the CRIM1 MO were
co-injected there were dramatic changes in cadherin labeling in
GFP expressing cells. At low magnification (Fig. 3C, D, E, F)
tracer positive regions have reduced immunoreactivity for both E-
cadherin and C-cadherin. Higher magnification (Fig. 3G, H, I, J)
shows the precise correlation between GFP expression and
reduced junctional labeling intensity. In addition, a junction
between two tracer positive cells generally has a low level of
cadherin immunoreactivity compared with junctions between a
tracer positive and a tracer negative pair or between two tracer
negative cell junctions (Fig. 3G, H, I, J). To quantify the E- and C-
cadherin labeling, we measured pixel intensities over a curved line
interval superimposed along junctional labeling between two cells.
When normalized to the value of junctions between pairs of tracer-
negative cells, a tracer positive-tracer negative pair showed no
reduction in labeling intensity whereas tracer-positive pairs
showed significantly reduced labeling intensity for E-cadherin
(Fig. 3K) and C-cadherin (Fig. 3L). At higher magnification, some
tracer positive cells have a rounded shape and a greater apical
surface area than their tracer-negative neighbors (Fig. 3G, H, I, J)
disrupting the pattern of cell packing.
While these changes in junctional cadherin levels and cell shape
were consistent with a role for CRIM1 in adhesion, it remained
possible that the cells with low cadherin levels were undergoing
apoptosis as a primary response to CRIM1 loss-of-function. To
determine whether this occurs, we performed two different assays
for cell death. First, we injected embryos with either the
fluorescent dextran tracer alone or with tracer plus 15 ng each
XLCA and B MOs into a dorsal blastomere at the 4-cell stage. We
harvested embryos at stage 13, permeablized and performed
whole-mount TUNEL labeling (Fig. S1). As a positive control, we
used the same combination of control and MO-injected embryos
but treated them with DNase I to nick genomic DNA and enhance
TUNEL labeling (Fig. S1). DNase I-treated embryos were
TUNEL labeled; control or XLCAB-injected embryos without
DNase-I treatment were not. Embryos were injected with the same
amount of MOs that reliably caused reduced junctional cadherin
labeling at the same analyzed stage (Fig. 3).
Since it can be argued that TUNEL labeling monitors a late
event in the activation of cell death pathways, we also performed
labeling for activated Caspase 3, an early marker of cell death
pathway activation combined with labeling for C-cadherin (Fig. 4A
and B). In this set of experiments, we analyzed CRIM1
knockdown embryos that showed a patch of de-adhering cells
judged morphologically (Fig. 4B). We performed quantification of
pixel intensity for the dextran tracer, C-cadherin and activated
Caspase 3 along 450 pixel line intervals extending through tracer-
negative to tracer-positive regions (Fig. 4A and B). These data are
graphically represented in pixel intensity histograms (Fig. 4C and
D). Regions of the micrograph containing the line interval are
reproduced at higher magnification below the histogram (Fig. 4E
and F). We analyzed 14 examples each of control MO and
XLCAB-injected embryos and found consistent results.
In embryos co-injected with the tracer and the standard control
MO, lineage tracer-positive cells retained strong C-cadherin
junctional staining (Fig. 4A, middle panel and 4C, red). Activated
caspase-3 levels, with the exception of the occasional positive cells
(Fig. 4A, blue arrowhead), were consistently low across the whole
Figure 2. Disruption of neural fold morphogenesis in CRIM1
MO injected embryos. Pigmented embryos showed neural tube
morphogenesis defects resulting from CRIM1 MO injection. In (A and B)
line intervals mark the distance from the midline to the neural folds to
emphasize the defect in morphogenesis that is a result of CRIM1 MO
injection. In (A and C) red arrowheads indicate a region of cells that is
sloughing from the embryo surface.
doi:10.1371/journal.pone.0032635.g002
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analysis (Fig. 4C, blue). By contrast, in embryos co-injected with
the tracer and 15 ng each XLCAB MO, C-cadherin labeling was
consistently lower in tracer-positive regions as seen in the
micrographs (Fig. 4B, middle panel, 4F, Ccad) and also when
comparing red channel pixel intensities in tracer-negative and
positive regions on the histogram (Fig. 4D).
We performed quantification of these signals by measuring pixel
intensities over 150 pixel line intervals located exclusively in tracer
negative (control MO and XLCAB injected embryos), tracer
positive, adherent (control MO and XLCAB injected embryos), or
tracer positive, non-adherent regions (XLCAB injected embryos
only) in 8 different embryos. In XLCAB injected embryos, C-
cadherin labeling was significantly reduced in both adherent and
non-adherent tracer-positive regions compared with tracer-
negative regions (Fig. 4G, red bars. A number lower than 1
indicates reduction of C-cadherin expression in MO injected
regions). Importantly, adherent, MOs injected regions with
reduced C-cadherin levels show no change in the level of activated
Caspase 3 (Fig. 4G, blue bars). In addition, activated caspase 3
levels only increase dramatically when cells show non-adherent
morphology (Fig. 4G, blue bars). These data argue that the
primary consequence of CRIM1 loss-of-function is a diminished
level of cadherin junctional complex and that cell de-adhesion
followed by activation of cell death pathways is a secondary
consequence.
CRIM1 is required for ß-catenin localization to junctional
complexes
The cadherin junction defects apparent in CRIM1 knockdown
experiments prompted us to determine whether CRIM1 might
regulate the level or distribution of other major adhesion complex
proteins. To assess this, we generated embryos co-injected with the
dextran tracer and control or XLCAB MOs and labeled for both
C-cadherin and ß-catenin. As described above, we chose to
analyze experimental embryos that had regions of non-adherent
cells as judged morphologically (Fig. 5B). This analysis is illustrated
and quantified as described for Fig. 4.
Control MO injected embryos showed levels of C-cadherin and
ß-catenin signal that were consistent across tracer-negative and
tracer-positive regions of the embryo (Fig. 5A, C, E, G). By
contrast, tracer-positive regions in XLCAB-injected embryos
showed reduced levels of both C-cadherin and ß-catenin
regardless of whether these regions were adherent or non-adherent
(Fig. 5B, D, F, H). To quantify the level of C-cadherin and ß-
catenin, we generated pixel intensities over 150 pixel intervals on
control MO-positive, and XLCAB-positive adherent and non-
adherent regions. We then quantified the changes in average pixel
intensities in MO-positive (tracer-positive) regions compare to
those in MO-negative regions for both C-cadherin and ß-catenin
labeling (Fig. 5I). Compared with control MO regions, the
XLCAB MO resulted in a mild but statistically significant
reduction in C-cadherin signal and a more pronounced reduction
in ß-catenin signal (Fig. 5I). Interestingly, the level of C-cadherin
signal reduced dramatically when cells become non-adherent
while ß-catenin signal showed no further reduction (Fig. 5G, H, I).
This suggested that a primary consequence of CRIM1 loss-of-
function is the failure of ß-catenin to stably associate with cadherin
junctional complexes.
Compromise of the cadherin junctional complex leads to
defects in apical-basal epithelial polarity [5]. To determine if this
feature of neural plate epithelial cells might be changed with
CRIM1 loss-of-function, we performed similar experiments by
co-injecting XLCAB with dextran tracer and performed
immunofluorescent labeling on cross sections of the neural
epithelium. Embryos displaying a mild phenotype were analyzed
midway through neurulation at stage 16. The tracer was
generally (Fig. 5K, green) but not always (Fig. 5J, green)
distributed in a region that abutted the midline as would be
expected for injection of a dorsal blastomere at the 4-cell stage.
Tracer positive regions had a markedly different labeling pattern
for ß-catenin. In unaffected neural epithelium (tracer negative,
Fig. 5J, K) the neural epithelium has intense ß-catenin labeling at
cell junctions and the columnar cell shape of the outermost
epithelial layers is distinct (tracer negative, Fig. 5 J, K, grayscale
panels). In all regions receiving the XLCAB MOs (Fig. 5 J, K,
green region with dashed white line boundary) junctional ß-
catenin labeling level is lower, the cells show a more rounded
shape and the epithelium is disorganized. Out of 24 embryos
each of experimental and control, we found polarity defects that
were restricted to the tracer-positive regions in 7 experimental
embryos.
We then determined whether restoration of CRIM1 expression
would rescue the abnormal distribution of ß-catenin in CRIM1
knockdown cells. To this end, a MO-resistant, FLAG-tagged full-
length CRIM1 mRNA (CRIM1-FL) was co-injected with XLCAB
MOs into a dorsal blastomere at the 4-cell stage. The expression
level of the tagged protein was measured by comparing average
pixel intensities over a 150 pixel line interval placed in tracer
positive and tracer negative areas (Fig. 6 A, B, C, white lines).
Injection of the mRNA resulted in robust expression of tagged full-
length CRIM1 with or without co-injection of XLCAB MOs
(Fig. 6B, C right panels, Fig. 6D blue bars). Whole-mount ß-
catenin labeling was performed on embryos injected with different
combinations of MOs and mRNA. We found that while injecting
CRIM1 mRNA alone did not change the expression of ß-catenin
(Fig. 6C, middle panel; Fig. 6E), co-injecting CRIM1 mRNA with
XLCAB MOs restored the ß-catenin intensity (Fig. 6A, B middle
panels) to the normal level of ß-catenin as in embryos injected with
control MO (Fig. 6E). Combined, these data suggest CRIM1 has
an essential role in stabilizing the cadherin junctions.
CRIM1 complexes with ß-catenin and N-cadherin via its
cytoplasmic domain
As a first step in understanding the mechanism of action of
CRIM1, we determined whether multiple CRIM1 molecules
could associate in a complex. We co-expressed a FLAG-tagged
ectodomain form (Fig. 7A, top line) with a series of deletion
Figure 3. CRIM1 is required for junctional localization of E- and C-cadherin in the neural plate. (A–J) Immunofluorescence labeling of
whole-mount Xenopus embryos after injection of translation-blocking XLCAB MOs. Embryos were co-injected with mRNA encoding GFP at the 4-cell
stage and were fixed and labeled at stage 13 (early neurula) with antibodies to GFP (green), E-cadherin (A, C, D, G, H, red) or C-cadherin (B, E, F, I, J,
red). Cadherin junctional complexes were visualized by combining multiple optical sections generated by confocal microscopy. In lower
magnification images (C, D, E, F) it is apparent that tracer positive regions have lower levels of cadherin immunoreactivity and are irregularly shaped.
In the magnified regions (G, H, I, J) indicated by white corner marks in (C, D, E, F) the loss of cadherin immunoreactivity in tracer positive cells is more
obvious. The gray line between panels indicates separated color channels of the same image. (K–L) Graphs show the measured average E-cadherin
(K) and C-cadherin (L) junctional staining intensity between two tracer-negative, one tracer negative and one tracer positive, or two tracer-positive
cells (n=20 pairs for each categories).
doi:10.1371/journal.pone.0032635.g003
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whether this would coimmunoprecipitate (co-IP) from HEK293
cells. According to immunoblots with appropriate antibodies, all
proteins expressed well (Fig. 7B, left panels) and the V5 tagged
proteins could also be efficiently IPd (Fig. 7B, far right). Anti-V5 IP
followed by immunoblot with anti-FLAG showed all deletion
mutants of V5 tagged CRIM1 could form complexes with
CRIM1-FL-ED (Fig. 7B, center left). These data indicate that
CRIM1 can form complexes where multiple CRIM1 molecules
are present. These data also show that an N-terminal region
containing the IGFBP-like domain is sufficient for formation of
this complex.
Figure 4. Cadherin junctional complex deficiency is the primary response to CRIM1 loss-of-function. (A–B) Embryos were injected with
either standard control MO or 15 ng each XLCAB MOs with dextran tracer (green), fixed at stage 13 and labeled for C-cadherin (Ccad) and activated
caspase 3 (aCasp3). In (A) the asterisk indicates a region where labeling in the apical junctional complex was not imaged due to the optical sectioning
plane. In (A and B), the blue arrowheads indicate isolated dying cells labeled positive for activated caspase 3. (C–D) Three-channel histograms
indicating pixel intensity along a line interval of 450 pixels in control MO (A and C) and XLCAB MO (B and D) injected embryos. (E–F) Magnified
images of regions along the line interval in (A and B) with color channel merge (top) and separated color channels corresponding to different labels
as indicated. (G) Quantification of relative expression levels of C-cadherin and activated Caspase 3 in standard control MO and XLCAB injected
embryos. The expression levels are determined by the ratio of average pixel intensities over 150-pixel intervals in tracer-positive regions and tracer-
negative regions within the same embryo. In XLCAB injected embryos, relative expression levels were measured over intervals placed exclusively in
tracer-positive, adherent regions or tracer positive, non-adherent regions (n=8 for all categories).
doi:10.1371/journal.pone.0032635.g004
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shown by knockdown and rescue experiments prompted us to
determine whether CRIM1 might directly interact with major
adhesion complex proteins. To this end we over-expressed
epitope-tagged CRIM1 in HEK293 cells, and determined whether
CRIM1 could be IPd in these complexes (data not shown). When
anti-ß-catenin antibodies were used for IP, CRIM1 was readily
detected by immunoblot (data not shown). We then generated
mutant forms of CRIM1 that lacked the cytoplasmic domain
(Fig. 7C). We also used two different locations for epitope tagging
given the possibility that a C-terminal epitope tag might prevent a
cytoplasmic domain interaction (Fig. 7C). All four modified
CRIM1 proteins expressed well in HEK293 cells (Fig. 7D, left
panel) and could be IPd effectively with the antibody to the
appropriate tag (Fig. 7D, right panel). Only CRIM1 with an intact
cytoplasmic domain would form a complex with ß-catenin
(Fig. 7D, center left) through IP using anti- ß-catenin antibodies.
To determine whether the cytoplasmic domain of CRIM1 was
sufficientforß-catenincomplexformation,weexpressedCRIM1-cyt
(consisting of the secretory leader, transmembrane and cytoplasmic
domains, Fig. 7E) in 293 cells and performed ß-catenin IPs. Both
CRIM1-cyt and the full-length CRIM1 expressed well as indicated
byan anti-V5immunoblotofcelllysates(Fig.7F,leftpanel– tracks3
and 4 are duplicates). Using anti-ß-catenin antibodies, both full-
length CRIM1 and CRIM1-cyt co-IPd (Fig. 7F, right panel). We
used antibodies to the FLAG epitope in CRIM1-FL and CRIM1-
FLDcyt(Fig.7G)inreciprocalIPsanddetectedß-catenin(Fig.7H)in
immunoblots. In lysates from CRIM1-FL expressing cells, total ß-
catenin levels appeared unchanged where a CRIM1-ß-catenin
complex was demonstrated via co-IP (Fig. 7I). These data provide
strong evidence that CRIM1 and ß-catenin exist in the same
complex. We could not convincingly demonstrate a direct
interaction between a variety of recombinant forms of the CRIM1
cytoplasmic domain and ß-catenin in vitro (data not shown).
The CRIM1 knockdown adhesion defect, together with co-
existence of CRIM1 and ß-catenin in a protein complex raised the
possibility of CRIM1 association with cadherins. N-cadherin is
expressed in HEK293 cells whereas E-cadherin is not (data not
Figure 5. CRIM1 is required for junctional localization of ß-catenin in the neural plate. (A–D) Whole-mount immunofluorescence labeling
of stage 13 Xenopus embryos in which standard control MO (A, C) or translation-blocking XLCAB MOs (B, D) were co-injected with dextran tracer at
the 4-cell stage. Embryos were labeled with antibodies to C-cadherin and ß-catenin as indicated. (C–D) Higher magnifications of the indicated
regions of (A and B). (E–F) Pixel intensity histograms of imuunofluorescence labeling for the line intervals shown in (A and B) respectively. (G–H)
Magnified regions corresponding to the line intervals shown in (A and B) with color channel merge (top) and separated color channels corresponding
to different labels as indicated. (I) Quantification of relative expression levels of C-cadherin and ß-catenin in standard control MO and XLCAB injected
embryos by normalizing average pixel intensities over 150-pixel line intervals in tracer-positive regions to those of tracer-negative regions within the
same embryo. In XLCAB injected embryos, relative expression levels were measured over intervals placed exclusively in tracer-positive, adherent
regions or tracer positive, non-adherent regions (n=20 in all categories) (J–K) Immunofluorescence labeling of cryosections from Xenopus embryos at
stage 16 (mid-neurula) of mildly affected embryos. MOs were co-injected with dextran tracer (green). Cryosections were labeled with Hoechst 33258
for nuclei (blue) and with antibodies to ß-catenin (J, K, white). Tracer-positive regions are outlined with a dashed white line. The gray line between
panels indicates separated color channels of the same image.
doi:10.1371/journal.pone.0032635.g005
Figure 6. Restoration of CRIM1 expression can rescue ß-catenin level in CRIM1 loss-of-function embryos. (A–C) Whole-mount
immunofluorescence labeling of stage 13 Xenopus embryos in which XLCAB MOs, MO-resistant mRNA of FLAG-tagged full-length CRIM1 (CRIM1-FL)
or a combination of the two were injected at the 4-cell stage, together with dextran tracer. In (A and C) the asterisks indicate regions where labeling
in the apical junctional complex were not imaged due to the optical sectioning plane. (D) Quantification of relative expression level of FLAG-tagged
CRIM1 protein by calculating the ratio of average pixel intensity of FLAG labeling over 150 pixel line intervals placed in tracer-positive or tracer-
negative regions (white bars in A–C). (E) Quantification of relative expression level of ß-catenin by calculating the ratio of average pixel intensity of ß-
catenin labeling over 150 pixel line intervals placed in tracer-positive or tracer-negative regions (white bars in A–C).
doi:10.1371/journal.pone.0032635.g006
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antibodies IPd CRIM1 (Fig. 7D). Formation of a CRIM1-N-
cadherin complex was also dependent upon the presence of an
intact CRIM1 cytoplasmic domain (Fig. 7C, D). Combined, these
data indicate that CRIM1 can form complexes with ß-catenin and
N-cadherin via its cytoplasmic domain. This, with reduced
junctional cadherin levels in Xenopus CRIM1 knockdown expreri-
ments, suggested that the adhesion defect resulted from disruption
of cadherin-dependent junctional complexes.
Discussion
In this report we assessed the function and mechanism of action
of the unique transmembrane molecule cysteine-rich motor
neuron 1 (CRIM1). Using antisense oligonucleotide knockdown
experiments in Xenopus laevis, we showed that CRIM1 is essential
for formation of the nervous system. Since the expression of early
neural markers is unaffected, CRIM1 clearly did not regulate the
inductive phases of neural development when BMP signaling is
involved. Rather, we provide evidence at both the cellular and
protein levels that CRIM1 is required for formation of cadherin-
dependent adhesion junctions. Specifically we show that CRIM1
can form complexes with ß-catenin and cadherins and that these
proteins are reduced in junctional complexes of CRIM1
knockdown Xenopus embryos. Combined, these data suggest
normally, CRIM1 is critical for the formation of cadherin
junctions in the developing neural plate. These findings raise
several questions.
CRIM1 function in cadherin-mediated morphogenesis
The classical cadherins have diverse roles in development and
homeostasis including mechanical cell-cell adhesion, coordination
of cell movements during morphogenesis, establishment and
maintenance of epithelial polarity as well as cell-to-cell signaling
and recognition [35]. There are different ways in which these
various cadherin activities are regulated, some are post-transcrip-
tional and therefore mediated by the interaction of cadherins with
other proteins. The association of ß-catenin with cadherins is
regulated by different phosphorylation states that have either
positive (serine phosphorylation of E-cadherin or ß-catenin) or
Figure 7. CRIM1 self-associates via the N-terminal domain and forms a complex with ß-catenin and N-cadherin via the C-terminal
domain. (A, C, E, G) Tables showing CRIM1 expression constructs used in pull-down assays and result summaries. (B) According to anti-V5
immunoprecipitations from the same whole-cell lysates, CRIM1-V5 (track 3), CRIM1-ED-V5 (track 4) and CRIM1-N1-V5 (track 5) all interact with CRIM1-
FL-ED suggesting multimerization via the N-terminal region represented in CRIM1-N1-V5. The immunoglobulin used for immunoprecipitation is
detected in the immunoblot of (B), right panels of each pair (Ig). (D) Anti-V5 and anti-FLAG (FL) immunoblots of whole-cell lysates show all CRIM
constructs shown in (C) express to abundant levels in 293 cells. Control anti-V5, anti-FLAG immunoprecipitation followed by anti-V5, anti-FLAG
immunoblot shows that CRIM1 proteins are readily detected. Immunoblots of the same immunoprecipitations with anti-ß-catenin or anti-N-cadherin
antibodies show that CRIM1 forms complexes with ß-catenin and N-cadherin but only if the CRIM1 cytoplasmic domain is present. The band in track 1
of D (blue arrowhead) is a background band. (F) Anti-V5 immunoblots of whole cell lysates (left panel) and anti-ß-catenin immunoprecipitations
(right panel) show a version of CRIM1 with the signal peptide, trans-membrane domain and cytoplasmic domain forms a complex with ß-catenin. (H)
immunoprecipitation using anti-FLAG antibodies in 293 cells expressing either CRIM1-FL or CRIM1-FLDcyt. ß-catenin co-immunoprecipitates with
CRIM1-FL, track 2, but not with CRIM1-FLDcyt, track 3. Track 4 shows a control IP from 293 cells expressing CRIM1-FL where no primary antibody was
added. No ß-catenin association is observed. (I) Co-immunoprecipitation of ß-catenin with FLAG-tagged CRIM1-FL with 293 whole cell lysate shows
detection of endogenous ß-catenin. Anti-tubulin western blot was shown as loading control. In all experiments, an equal proportion of lysate is
represented on compared gel tracks.
doi:10.1371/journal.pone.0032635.g007
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formation [36]. Other levels of cadherin negative regulation
include cleavage of the extracellular domain by ADAM (a
disintegrin and metalloprotease domain) 10 [37] and cleavage of
the intracellular domain by proteases such as c-secretase/
presenilin-1 [38] thus promoting disassembly of the cadherin
complex. Cadherin endocytosis into clathrin-coated vesicles [39]
may also negatively regulate cell-cell junctional adhesiveness
perhaps as a consequence of the loss of p120 catenin association
[40].
In this study, we show that CRIM1 has an essential role in cell-
cell adhesion during development of the central nervous system.
CRIM1 appears to lack any intrinsic capacity to mediate cell-cell
adhesion (unpublished results) yet it seems essential for the
formation or stabilization of cadherin-dependent adhesion
complexes. A comparison of the expression patterns of CRIM1
and cadherins within epithelia reveals that CRIM1 is expressed in
sub-regions within larger cadherin-positive domains. An example
is the presumptive lens in the mouse where CRIM1 is first
expressed in a patch of ectoderm that will invaginate to form the
lens pit [19]. This small region of presumptive lens ectoderm is
part of the larger embryonic head ectoderm that expresses E-
cadherin [41]. Similarly, the region of the Xenopus neural plate
that expresses CRIM1 is part of a larger surface ectoderm that
expresses cadherins [42,43,44]. The CRIM1 expressing neural
plate will, like the presumptive lens, undergo dramatic morpho-
genesis at the time CRIM1 is expressed [45]. The mild
morphogenesis phenotype observed in the CRIM1 knockdown
experiments is similar to the failure of hinge point formation in
neural tube bending induced by knockdown of the actin
associated protein, Shroom [46]. Connectivitity to the cytoskel-
eton is important for stabilization of cadherin junctional
complexes. CRIM1 is not obligatorily expressed in cadherin-
positive regions suggesting that it is not universally required for
the formation or stabilization of adhesion complexes. CRIM1
may become essential for the function of cadherin where it is
expressed, perhaps displacing another cadherin complex stabili-
zation mechanism thus regulating adhesive activity perhaps
during morphogenesis.
Cell-cell adhesion between animal cells undergoing normal
morphogenetic movements, as in the bending of epithelial sheets,
must be dynamic without losing cell-cell contact. Kametani and
Takeichi demonstrated basal-to-apical cadherin flow occurs at cell
junctions between moving transformed cells in culture [47]. They
visualized junctional instability and cadherin-catenin-actin protein
rearrangements at sites of cellular morphogenesis while maintain-
ing cell contact. CRIM1 may play role in regulating cadherin-
catenin junctional stability. We show CRIM1 interaction with
these proteins and expression in sites where epithelial sheet
bending and dynamic cellular rearrangement occurs.
CRIM1 mechanism of action
Beyond the demonstration that the 82 residue intracellular
domain of CRIM1 is required for association with ß-catenin and
cadherins, the mechanism of complex formation is unclear. The
cytoplasmic domain of CRIM1 is highly conserved but does not
have obvious interaction motifs. In particular, there are no
primary sequence features of typical ß-catenin ligands. Proteins
that bind ß-catenin in an extended conformation along the
armadillo repeat (ARM) domain (such as the cadherins, ICAT,
TCFs, APC) are characterized by a DXHHXWX2–7E motif where
H is an aliphatic residue, and W an aromatic residue [48]; there is
no such motif in CRIM1. Furthermore, ligands that bind in the
positively charged groove of the ß-catenin ARM domain are
typically acidic (calculated pI (isoelectric point) for the cadherins is
3.3, for APC, 4.1, and for the Tcf family, 4.4). The calculated pI of
the CRIM1-cytoplasmic domain is 9.8.
Thus, it may not be surprising that we were unable to
demonstrate a direct interaction of recombinant forms of the
CRIM1 cytoplasmic domain and ß-catenin or between the
CRIM1 cytoplasmic domain and the N-cadherin cytoplasmic
domain (data not shown). This suggests that the formation of a
complex between CRIM1, ß-catenin and cadherin may depend on
additional proteins that might have a bridging activity or perhaps
on post-translational modifications.
Association of ß-catenin with cadherins in the endoplasmic
reticulum (ER) is important for efficient transit of the complex to
the plasma membrane and formation of adhesion complexes [49].
Some characteristics of CRIM1 are consistent with participation
in this pathway. For example, in vascular endothelial cells,
CRIM1 moves to the membrane from the ER upon activation
with an inflammatory stimulus [21]. It has also been shown that
that CRIM1 can interact with bone morphogenetic proteins via its
extracellular domain and can retain them in the ER as a way of
suppressing their activity [22]. Combined with data presented in
this report, these findings might suggest that a critical cellular
location for CRIM1 is the ER and furthermore, that CRIM1
might associate with ß-catenin and cadherins in this location.
Further investigation of this proposal is required.
Supporting Information
Figure S1 Cell apoptosis does not occur prior to loss of
junctional cadherions in CRIM1 MO injected embryos.
(A and B) TUNEL labeling of stage 13 control (A) or XLCAB
injected (B) embryos with color channel merge on top and
TUNEL channel alone at bottom. (C and D) TUNEL labeling of
stage 13 control (C) or XLCAB injected (D) embryos treated with
DNase I to manually nick genomic DNA. Color channel merges
are on top and TUNEL alone shown at bottom.
(TIF)
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